Human microbiome research is one of the most relevant fields of innovation, based on the large range of applications in human microbiome research, and the similarly wide range of sectors that are currently or potentially involved in the area.
The US therapeutics market is meant to reach $6.9 billion by 2024, according to research conducted by IP Pragmatics. Microbiome research and innovation will be the key in reaching this prediction. Ted Dinan, the Emeritus Professor of Psychiatry and a Principal Investigator in APC Microbiome Ireland at University College Cork, talks to Atlantia Clinical Trials about the current state and the future of human microbiome research and markets.